Ignite Creation Date:
2024-05-06 @ 4:14 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04920747
Status:
COMPLETED
Last Update Posted:
2021-06-10
First Post:
2021-06-04
Brief Title:
Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients
Sponsor:
Centre Hospitalier Universitaire de Besancon
Organization:
Centre Hospitalier Universitaire de Besancon
Organization Data
Organization:
Centre Hospitalier Universitaire de Besancon
Class:
OTHER
Study ID:
2021622
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None